{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T05:29:52Z","timestamp":1794806992630,"version":"4.9.1"},"reference-count":12,"publisher":"Elsevier","isbn-type":[{"value":"9780443428517","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006332","name":"Association Laurette Fugain","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006332","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004562","name":"Minist\u00e8re de l&apos;Enseignement sup\u00e9rieur et de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004562","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007391","name":"Association pour la Recherche sur le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004097","name":"Fondation ARC pour la Recherche sur le Cancer","doi-asserted-by":"publisher","award":["ARCPGA2022120005710_6354"],"award-info":[{"award-number":["ARCPGA2022120005710_6354"]}],"id":[{"id":"10.13039\/501100004097","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.mcb.2025.03.015","type":"book-chapter","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T16:43:20Z","timestamp":1744735400000},"page":"1-12","source":"Crossref","is-referenced-by-count":3,"title":["High-throughput cell viability assessment using a luminescent ATP detection assay"],"prefix":"10.1016","author":[{"given":"Dana","family":"Alawieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Leduc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastien","family":"Nakhla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Renneville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Kepp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/bs.mcb.2025.03.015_bib1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41408-024-01054-2","article-title":"RAS mutations in myeloid malignancies: Revisiting old questions with novel insights and therapeutic perspectives","volume":"14","author":"Alawieh","year":"2024","journal-title":"Blood Cancer Journal"},{"key":"10.1016\/bs.mcb.2025.03.015_bib2","unstructured":"CellTiter-Glo\u00ae Luminescent Cell Viability Assay Technical Bulletin. Literature # TB288 https:\/\/france.promega.com\/en\/resources\/protocols\/technical-bulletins\/0\/celltiter-glo-luminescent-cell-viability-assay-protocol\/."},{"issue":"6","key":"10.1016\/bs.mcb.2025.03.015_bib3","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1038\/s41375-021-01207-3","article-title":"Chronic myelomonocytic leukemia diagnosis and management","volume":"35","author":"Chan","year":"2021","journal-title":"Leukemia: Official Journal of the Leukemia Society of America, Leukemia Research Fund, UK"},{"issue":"2","key":"10.1016\/bs.mcb.2025.03.015_bib4","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/ana.25286","article-title":"Clinical validation of blood\/brain glutamate grabbing in acute ischemic stroke","volume":"84","author":"Da Silva\u2010Candal","year":"2018","journal-title":"Annals of Neurology"},{"issue":"4","key":"10.1016\/bs.mcb.2025.03.015_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0302223","article-title":"Forskolin-mediated cAMP activation upregulates TNF-\u03b1 expression despite NF-\u03baB downregulation in LPS-treated Schwann cells","volume":"19","author":"Henry","year":"2024","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/bs.mcb.2025.03.015_bib6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ccell.2017.11.012","article-title":"Cooperative epigenetic remodeling by TET2 loss and NRAS mutation drives myeloid transformation and MEK inhibitor sensitivity","volume":"33","author":"Kunimoto","year":"2018","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/bs.mcb.2025.03.015_bib7","doi-asserted-by":"crossref","first-page":"772","DOI":"10.3390\/cells13090772","article-title":"Globospiramine from Voacanga globosa exerts robust cytotoxic and antiproliferative activities on cancer cells by inducing caspase-dependent apoptosis in A549 cells and inhibiting MAPK14 (p38\u03b1): In vitro and computational investigations","volume":"13","author":"Manzano","year":"2024","journal-title":"Cells"},{"issue":"10","key":"10.1016\/bs.mcb.2025.03.015_bib8","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1038\/s41375-021-01330-1","article-title":"Increasing recognition and emerging therapies argue for dedicated clinical trials in chronic myelomonocytic leukemia","volume":"35","author":"Renneville","year":"2021","journal-title":"Leukemia: Official Journal of the Leukemia Society of America, Leukemia Research Fund, U. K"},{"issue":"1","key":"10.1016\/bs.mcb.2025.03.015_bib9","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12885-023-10645-4","article-title":"Phenotypic screening platform identifies statins as enhancers of immune cell-induced cancer cell death","volume":"23","author":"Selvin","year":"2023","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/bs.mcb.2025.03.015_bib10","doi-asserted-by":"crossref","first-page":"13093","DOI":"10.1038\/s41598-020-70143-6","article-title":"In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication","volume":"10","author":"Touret","year":"2020","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.mcb.2025.03.015_bib11","doi-asserted-by":"crossref","first-page":"1221578","DOI":"10.3389\/fcell.2023.1221578","article-title":"The action of physiological and synthetic steroids on the calcium channel CatSper in human sperm","volume":"11","author":"Wehrli","year":"2023","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"14","key":"10.1016\/bs.mcb.2025.03.015_bib12","doi-asserted-by":"crossref","first-page":"7929","DOI":"10.3390\/ijms25147929","article-title":"Novel piperazine derivatives of vindoline as anticancer agents","volume":"25","author":"Zsoldos","year":"2024","journal-title":"International Journal of Molecular Sciences"}],"container-title":["Methods in Cell Biology","2D and 3D cellular screening models and AI guided analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091679X25000962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091679X25000962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T23:17:57Z","timestamp":1776122277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091679X25000962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443428517"],"references-count":12,"URL":"https:\/\/doi.org\/10.1016\/bs.mcb.2025.03.015","relation":{},"ISSN":["0091-679X"],"issn-type":[{"value":"0091-679X","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}